share_log

GlucoTrack And 2 Other Stocks Under $1 Insiders Are Buying

Benzinga ·  Apr 25 21:03

The Dow Jones index closed lower by around 0.1% on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Tecogen

  • The Trade: Tecogen Inc. (OTC:TGEN) Director Earl R Lewis bought a total of 10,000 shares at an average price of $0.68. To acquire these shares, it cost around $6,800. The company's Director John Hatsopoulos also bought 5,000 shares.
  • What's Happening: Tecogen is expected to release first-quarter financial results on Thursday, May 9.
  • What Tecogen Does: Tecogen Inc, designs, manufactures, markets, and maintains high-efficiency, ultra-clean cogeneration products. It operates in three business segments, namely Products, Services, and Energy Production.

Bespoke Extracts

  • The Trade: Bespoke Extracts, Inc. (OTC:BSPK) CEO Michael Feinsod acquired a total of 5,000 shares at an average price of $0.11. To acquire these shares, it cost around $550.
  • What's Happening: The company's stock lost around 22% over the past six months.
  • What Bespoke Extracts Does: Bespoke Extracts Inc is focused on selling its proprietary line of specially-formulated, premium quality, hemp-derived CBD products.

GlucoTrack

  • The Trade: GlucoTrack, Inc. (NASDAQ:GCTK) Director Drew Sycoff acquired a total of 182,540 shares at an average price of $1.26. The insider spent around $230,000 to buy those shares.
  • What's Happening: GlucoTrack recently announced closing of private placement.
  • What GlucoTrack Does: GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics.

Check This Out: Jim Cramer Says This Energy Stock Is 'Terrific,' Calls Casey's General Stores A 'Winner'

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment